RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles.
Michael A LongoSunetra RoyYue ChenKarl-Heinz TomaszowskiAndrew S ArvaiJordan T PepperRebecca A BoisvertSelvi KunnimalaiyaanCaezanne KeshvaniDavid SchildAlbino BacollaGareth J WilliamsJohn A TainerKatharina SchlacherPublished in: Nature communications (2023)
RAD51C is an enigmatic predisposition gene for breast, ovarian, and prostate cancer. Currently, missing structural and related functional understanding limits patient mutation interpretation to homology-directed repair (HDR) function analysis. Here we report the RAD51C-XRCC3 (CX3) X-ray co-crystal structure with bound ATP analog and define separable RAD51C replication stability roles informed by its three-dimensional structure, assembly, and unappreciated polymerization motif. Mapping of cancer patient mutations as a functional guide confirms ATP-binding matching RAD51 recombinase, yet highlights distinct CX3 interfaces. Analyses of CRISPR/Cas9-edited human cells with RAD51C mutations combined with single-molecule, single-cell and biophysics measurements uncover discrete CX3 regions for DNA replication fork protection, restart and reversal, accomplished by separable functions in DNA binding and implied 5' RAD51 filament capping. Collective findings establish CX3 as a cancer-relevant replication stress response complex, show how HDR-proficient variants could contribute to tumor development, and identify regions to aid functional testing and classification of cancer mutations.
Keyphrases
- dna repair
- dna damage
- papillary thyroid
- crispr cas
- prostate cancer
- single molecule
- dna binding
- squamous cell
- case report
- crystal structure
- machine learning
- copy number
- squamous cell carcinoma
- lymph node metastasis
- high throughput
- gene expression
- magnetic resonance imaging
- transcription factor
- young adults
- magnetic resonance
- living cells
- mass spectrometry
- data analysis
- fluorescent probe
- drug induced
- binding protein